From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need

Michail Kokkorakis; Chrysoula Boutari; Niki Katsiki; Christos S Mantzoros

doi:10.1016/j.metabol.2023.155664

From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need

Metabolism. 2023 Oct:147:155664. doi: 10.1016/j.metabol.2023.155664. Epub 2023 Jul 28.

Authors

Michail Kokkorakis¹, Chrysoula Boutari¹, Niki Katsiki², Christos S Mantzoros³

Affiliations

¹ Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
² Department of Nutritional Sciences and Dietetics, International Hellenic University, 57400 Thessaloniki, Greece.
³ Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Medicine, Boston VA Healthcare System, Boston, MA, USA. Electronic address: [email protected].

PMID: 37517792
DOI: 10.1016/j.metabol.2023.155664

No abstract available

Keywords: Cardiometabolic; Cirrhosis; FLD; Genetics; Lipodystrophy; MAFLD; MASH; MASLD; Metabolic syndrome; Metabolism; NAFLD; NASH; SLD; Sarcopenia.

Publication types

Editorial

MeSH terms

Humans
Longitudinal Studies
Metabolic Diseases*
Metabolic Syndrome*
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / metabolism